CinCor Pharma, Inc. (CINC): Successful IPO

September 23, 2022

BACKGROUND CinCor is a clinical-stage biopharmaceutical company focused on developing baxdrostat, a hypertension (HTN) drug for patients with resistant hypertension (rHTN) or uncontrolled hypertension (uHTN) with the goal of providing improved treatment for patients suffering from hypertension and not yet at goal. At the request of the CFO, LifeSci Advisors started working with CinCor a…

Read More